The Indiana State Dept. of Health and Eli Lilly and Company, with support from the Food and Drug Administration, today announced a partnership to accelerate testing in Indiana for the new coronavirus.
“This partnership between the Indiana State Department of Health and Eli Lilly and Company will be transformational in our efforts to accelerate testing for COVID-19,” Indiana Governor Eric Holcomb stated. “We are grateful for Lilly’s dedication to the health and safety of Hoosiers as we continue to put all of our focus into slowing the spread.”
Eli Lilly will use its research laboratories to analyze samples taken in Indiana healthcare facilities, including nursing homes and emergency rooms, in an effort to increase the state’s ability to conduct testing for COVID-19, the disease stemming from the new coronavirus, according to a press release. As Eli Lilly’s testing capacity expands, Eli Lilly and the ISDH will work together to increase testing.
In addition, Eli Lilly is piloting drive-through testing that may eventually be able to test patients outside of a healthcare facility to avoid spread of the virus, according to the company. The company hopes to have additional details in the coming days.
Eli Lilly reported it will not accept money from government agencies, hospitals, insurance companies or patients for conducting or analyzing tests.